Nucleosome-Releasing Treatment Makes Surviving Tumor Cells Better Targets for Nucleosome-Specific Anticancer Antibodies

10.1016/0165-2478(95)00066-E

Iakoubov LZ, 1997, Oncol Res, 9, 439

Jacob L, 1989, Proc Natl Acad Sci U S A, 86, 4669, 10.1073/pnas.86.12.4669

Koutouzov S, 1996, Eur J Immunol, 26, 472, 10.1002/eji.1830260230

5VP Torchilin, and LZ Iakoubov .Enhanced site-specific tumor therapy with monoclonal antibodies. In: Proc 1st World Meeting APGI/APV, Budapest.1995 :845-846.

Iakoubov LZ, 1995, Cancer Biother Radiopharm, 8, 299

10.1084/jem.180.2.433

10.1084/jem.177.5.1367

Arends MJ, 1991, Int Rev Exp Pathol, 32, 223, 10.1016/B978-0-12-364932-4.50010-1

Bell DA, 1991, Clin Immunol Immunopathol, 60, 13, 10.1016/0090-1229(91)90108-M

Fournie GL, 1993, Gerontology, 39, 215, 10.1159/000213536

10.1016/0304-3835(95)03742-F

10.1016/0960-0760(95)00034-W

Losman JA, 1993, Arthritis Rheum, 36, 552, 10.1002/art.1780360417

Sun XM, 1992, Anal Biochem, 204, 351, 10.1016/0003-2697(92)90251-2

Kedar E, 1992, Adv Cancer Res, 59, 245, 10.1016/S0065-230X(08)60308-5

10.1007/s002620050112

Jain RK, 1990, Cancer Metast Rev, 9, 253, 10.1007/BF00046364

Znati CA, 1996, Cancer Res, 56, 964